@article{ACS15784,
author = {Kunal D. Kotkar and Sameh M. Said and Joseph A. Dearani and Hartzell V. Schaff},
title = {Hypertrophic obstructive cardiomyopathy: the Mayo Clinic experience},
journal = {Annals of Cardiothoracic Surgery},
volume = {6},
number = {4},
year = {2017},
keywords = {},
abstract = {Background: Hypertrophic cardiomyopathy (HCM) is a primary myocardial disease characterized by left ventricular hypertrophy in the absence of other etiologies. Clinical presentation may vary from asymptomatic to sudden cardiac death. Medical treatment is the first-line therapy for symptomatic patients. Extended left ventricular septal myectomy is the procedure of choice if medical treatment is unsuccessful or intolerable.
Mayo Clinic experience: More than 3,000 patients have had septal myectomy for HCM at the Mayo Clinic (MN, USA) from 1993 to 2016. Risk of hospital death after isolated septal myectomy for obstructive HCM is },
issn = {2304-1021}, url = {https://www.annalscts.com/article/view/15784}
}